Celine Dubath

Prilly, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Psychotropic drug-induced weight gain and untargeted metabolomics: machine learning-driven results from a prospective cohort study.

Psychotropic drug-induced weight gain and untargeted metabolomics: machine learning-driven results from a prospective cohort study.

Journal: Translational psychiatry

Published: September 26, 2025

CYP2D6 Genotypes Do Not Affect Clozapine Levels in a Large, Multicenter Cohort: Time Has Come to Revise Food and Drug Administration's Clozapine Packet Insert.

CYP2D6 Genotypes Do Not Affect Clozapine Levels in a Large, Multicenter Cohort: Time Has Come to Revise Food and Drug Administration's Clozapine Packet Insert.

Journal: Schizophrenia bulletin

Published: July 06, 2025

Antipsychotic prescribing in adults : what to watch out for ?

Antipsychotic prescribing in adults : what to watch out for ?

Journal: Revue medicale suisse

Published: September 20, 2023

DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study.

DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study.

Journal: Clinical epigenetics

Published: September 12, 2023

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.

Journal: The Lancet regional health. Europe

Published: August 30, 2022

Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.

Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.

Journal: BMC psychiatry

Published: July 08, 2022

Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study.

Daily Dose Effects of Risperidone on Weight and Other Metabolic Parameters: A Prospective Cohort Study.

Journal: The Journal of clinical psychiatry

Published: May 13, 2022

Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema.

Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema.

Journal: Obesity facts

Published: April 28, 2022

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.

Journal: Molecular psychiatry

Published: April 20, 2022

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.

Journal: BMC psychiatry

Published: January 24, 2022

Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.

Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.

Journal: Basic & clinical pharmacology & toxicology

Published: November 04, 2021

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.

Journal: Translational psychiatry

Published: October 08, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026